Neurobiological Tech (NTII) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurobiological Tech (NTII)

NTII 0.0001000

0.0%

Mar 7 3:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Craig S. Owens who wrote (753)	1/19/2000 2:14:00 PM
From: BRAVEHEART	Read Replies (1) of 1494

Hi Craig, The document appears to deliniate rights of each individual party to Memantine. ie Allergan MERZ NTII & CCMC. Rights & profit sharing. Of course the profit sharing is met with an * % INDICATION MERZ NTI CCMC Merz Indication* []% []%,** []%,* CMCC Indications, []% []%,* []%,* *** John do I read it right. Will MERZ handle the manufacturing of Memantine. Memantine obviously has many potential targets as John has described in the past. This document appears to address who has rights to what. Then there is the constant reference to marketing & distribution partners. Clearly the necessary groundwork for things to come. Negotiating leverage just went up with the successful P-2B trials. BEST WISHES Jeffrey

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next